abagovomab 14
abciximab 25
abituzumab 11
abrilumab 0
actoxumab 8
adalimumab 7
aducanumab 3
afasevikumab 3
alacizumab_pegol 0
alemtuzumab 22
alirocumab 6
amatuximab 8
andecaliximab 13
anifrolumab 15
anrukinzumab 11
aprutumab 9
aprutumab_ixadotin 9
arcitumomab 7
ascrinvacumab 14
atezolizumab 4
atinumab 15
avelumab 5
basiliximab 10
bavituximab 6
begelomab 9
benralizumab 18
bevacizumab_beta 7
bezlotoxumab 8
bimagrumab 11
bleselumab 15
blinatumomab 18
blosozumab 11
bococizumab 13
brazikumab 13
brentuximab_vedotin 11
briakinumab 11
brodalumab 8
brolucizumab 14
brontictuzumab 11
burosumab 13
cabiralizumab 12
camrelizumab 3
canakinumab 8
cantuzumab_ravtansin 20
carlumab 13
carotuximab 4
cergutuzumab_amunaleukin2 16
cergutuzumab_amunaleukin 16
certolizumab_pegol 13
cetiximab 22
citatuzumab_bogatox 18
cixutumumab 19
clivatuzumab_tetraxetan 10
codrituzumab 19
conatumumab 14
concizumab 11
crenezumab 16
crizanlizumab 13
crotedumab 15
dacetuzumab 14
daclizumab 7
dalotuzumab 17
dapirolizumab_pegol 14
daratumumab 11
dectrekumab 7
demcizumab 15
denosumab 3
depatuxizumab 16
depatuxizumab_mafodotin 16
dezamizumab 12
dinutuximab 14
diridavumab 6
domagrozumab 0
drozitumab 14
duligotuzumab 10
durvalumab 7
dusigitumab 19
efalizumab 20
efungumab 8
eldelumab 10
elezanumab 9
elgemtumab 5
elotuzumab 11
emactuzumab 6
emapalumab 11
emibetuzumab 11
enavatuzumab 12
enfortumab_vedotin 6
enoblituzumab 10
enokizumab 12
enoticumab 13
ensituximab 16
eptinezumab 3
erenumab 14
etaracizumab 10
etrolizumab 21
evinacumab 7
evolocumab 7
farletuzumab 0
fasinumab 15
fezakinumab 13
fibatuzumab 9
ficlatuzumab 21
firivumab 14
flanvotumab 13
fletikumab 12
foralumab 8
foravirumab 12
fremanezumab 17
fresolimumab 10
fulranumab 11
futuximab 11
galcanezumab 8
ganitumab 19
gantenerumab 8
gemetuzumab 16
gemtuzumab2 9
gemtuzumab 10
gevokizumab 18
girentuximab 11
glembatumumab 17
glembatumumab_vedotin 17
guselkumab 24
ibalizumab 16
ibritumomab 10
icrucumab 12
idarucizumab 23
ifabotuzumab 9
imalumab 8
imgatuzumab 18
inclacumab 10
indatuximab_ravtansin 19
indusatumab 14
inebilizumab 14
intetumumab 5
iodine_girentuximab 10
ipilimumab 4
iratumumab 4
isatuximab 16
itolizumab 0
ixekizumab 15
labetuzumab_govitecan 17
lambrolizumab 12
lampalizumab 15
lanadelumab 14
landogrozumab 3
laprituximab 7
lebrikizumab 20
lendalizumab 16
lenzilumab 12
lifastuzumab_vedotin 7
ligelizumab 9
lilotomab 17
lirilumab 14
lodelcizumab 17
lokivetmab 7
lorvotuzumab_mertansin 3
lucatumumab 10
lumretuzumab 16
lupartumab 9
lutikizumab 9
margetuximab 15
milatuzumab 9
mirvetuximab 16
mirvetuximab_soravtansin 16
modotuximab 24
mogamulizumab 16
monalizumab 13
motavizumab 22
moxetumomab_pasudotox 11
namilumab 16
naratuximab 24
naratuximab_emtansin 24
narnatumab 12
navicixizumab2 17
navicixizumab 15
navivumab 13
necitumumab 13
nemolizumab 23
nesvacumab 0
nivolumab 12
obiltoxaximab 6
obinutuzumab 22
ocaratuzumab 11
ofatumumab 12
olaratumab 14
olokizumab 15
omalizumab 14
onartuzumab 12
ontuxizumab 11
opicinumab 9
orticumab 0
otelixizumab 13
oxelumab 3
ozanezumab 16
pamrevlumab 3
panobacumab 19
parsatuzumab 16
pasotuxizumab 7
pateclizumab 8
patritumab 10
pembrolizumab 12
perakizumab 9
pidilizumab 11
pinatuzumab_vedotin 14
plozalizumab 11
pogalizumab 21
polatuzumab_vedotin 15
ponezumab 15
prezalumab 14
pritoxaximab 22
quilizumab 7
racotumomab 14
radretumab 5
ralpancizumab 19
ramucirumab 9
ranevetmab 13
ranibizumab 9
refanezumab 12
remtolumab 5
rilotumumab 21
rinucumab 9
risankizumab 9
rituximab 13
rivabazumab 13
robatumumab 10
roledumab 8
romosozumab 9
rontalizumab 19
rosmantuzumab 11
rozanolixizumab 10
sacituzumab 18
sacituzumab_govitecan 18
samalizumab 21
sapelizumab 9
sarilumab 0
secukinumab 13
seribantumab 4
setoxaximab 17
sifalimumab 8
siltuximab 11
simtuzumab 16
sirukumab 6
solanezumab 19
solitomab 14
stamulumab 10
suptavumab 16
suvizumab 14
tabalumab 14
tadocizumab 15
tamtuvetmab 14
tanezumab 17
tarextumab 3
tavolixizumab 3
telisotuzumab 15
teplizumab 15
tesidolumab 3
tezepelumab 17
tigatuzumab 9
tildrakizumab 14
timolumab 7
tisotumab 6
tosatoxumab 19
tositumomab 10
tralokinumab 25
trastuzumab 19
tregalizumab 9
trevogrumab 5
ublituximab 14
urelumab 16
ustekinumab 16
utomilumab 8
vadastuximab 13
vadastuximab_talirin 13
vandortuzumab_vedotin 10
vantictumab 16
vanucizumab2 7
vanucizumab 19
varlilumab 10
vatelizumab 17
vedolizumab 13
veltuzumab 7
vesencumab 7
vorsetuzumab 17
vorsetuzumab_mafodotin 17
vunakizumab 15
xentuzumab 10
zatuximab 24
